CSN Login
Members Online: 14

Trial: anti-PD1 and anti-KIR combined

Alexandra's picture
Posts: 1310
Joined: Jul 2012


This trial sounds very promising. It combines two experimental drugs, the much-sought-after PD-1 drug BMS-936558 (nivolumab) and an anti-KIR drug BMS-986015. This trial is available to qualified patients with colorectal cancer, kidney cancer, melanoma, NSCLC (non-small cell lung cancer), and ovarian cancer. The trial is underway in Baltimore, Chicago, and New York.

Note: This trial is not yet recruiting in Boston or Portland.



Posts: 1
Joined: Jun 2014

Curious if anyone has particiapted in this trial.  I am just starting my search for a promising trial that includes Anti-PD1.

Subscribe with RSS
About Cancer Society

The content on this site is for informational purposes only. It is not a substitute for professional medical advice. Do not use this information to diagnose or treat a health problem or disease without consulting with a qualified healthcare provider. Please consult your healthcare provider with any questions or concerns you may have regarding your condition. Use of this online service is subject to the disclaimer and the terms and conditions.

Copyright 2000-2015 © Cancer Survivors Network